Last edition
News about "Pfizer"
Pfizer, Novartis, Roche Lead Net-Zero Pharma Supply Chain Transition
Europe currently dominates the global net-zero pharma supply chain market supported by strict climate regulations, while Asia-Pacific is the fastest-growing region, spurred by new government-led sustainability policies.
Pfizer | 11/09/2025 | By Dineshwori
DPIIT, Pfizer Ink Partnership to Support MedTech Startups
The Pfizer INDovation programme will empower DPIIT-recognised startups with grants of up to INR 60 lakhs each, along with a tailored 18-month incubation programme delivered by Social Alpha.
<br />
Pfizer | 05/09/2025 | By Dineshwori
Merck, BMS, Pfizer to Be Hit Hard by Looming Patent Cliff: Report Warns
Major pharmaceutical players, including Merck, Bristol Myers Squibb (BMS), Johnson and Johnson, Pfizer, and Novartis, are expected to experience significant revenue losses as several of their blockbuster drugs approach patent expirations, according to a new report by Research and Markets.
Pfizer | 28/07/2025 | By Dineshwori | 175
Pfizer and BioNTech's Updated COVID-19 Vaccine Secures EMA Nod, Awaits Final EU Approval
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorisation for Pfizer- BioNTech's LP.8.1-adapted monovalent COVID-19 vaccine in the European Union.
Pfizer | 28/07/2025 | By Dineshwori
The global biologics and biosimilars market is expected to reach approximately USD 600 billion by 2032, expanding at a compound annual growth rate (CAGR) of around 6.33 percent during the forecast period.
Pfizer | 15/07/2025 | By Dineshwori
Pfizer Signs Marketing and Supply Deal with Mylan Pharmaceuticals
Under the terms of the agreement, Pfizer will retain ownership of the brands, while Mylan will be responsible for their marketing and sales within India for a period of five years.
Pfizer | 25/02/2025 | By Aishwarya | 352
Alloy Therapeutics and Pfizer to Develop New Antibody Discovery Platform
Pfizer and Alloy have collaborated on various antibody discovery efforts, including the use of Alloy's ATX-CLC platform.
Pfizer | 12/02/2025 | By Aishwarya | 117
Acepodia Signs Strategic Clinical Partnership with Pfizer for Autoimmune Diseases
Under this new agreement, Pfizer Ignite will provide strategic guidance and resources to Acepodia as the company develops its cell therapies for oncology and autoimmune diseases.
Pfizer | 04/09/2024 | By Aishwarya | 272
Flagship Pioneering and Quotient Therapeutics Signs Deal with Pfizer
Pioneering Medicines, Flagship’s in-house drug discovery and development unit, is responsible for leading the strategic partnership with Pfizer, including driving the exploration process to rapidly surface potential drug development programs built on Flagship’s diverse bioplatforms and modalities.
Pfizer | 29/08/2024 | By Aishwarya | 224
Pfizer | 21/07/2023 | By Sudeep Soparkar | 544
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy